Arcutis Biotherapeutics Inc

NASDAQ:ARQT

10.02

-0.16 (-1.52%)

7:40:39 PM EDT: $9.95 -0.07 (-0.70%)

Market Cap (Intraday)	1.15B
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$36.82 Million
Adjusted EPS	-$0.41

See more estimates

10-Day MA	$9.85
50-Day MA	$9.80
200-Day MA	$8.60

See more pivots

Arcutis Biotherapeutics Inc Stock, NASDAQ:ARQT

3027 Townsgate Road, Suite 300, Westlake Village, California 91361

United States of America

Phone: +1.805.418.5006

Number of Employees: 296

http://www.arcutis.com

Description

Arcutis Biotherapeutics, Inc. engages in the development and commercialization of treatments for dermatological diseases. Its pipeline consists of topical treatments for plaque psoriasis, atopic dermatitis, hand eczema, vitiligo, scalp psoriasis, alopecia areata, and seborrheic dermatitis. The company was founded by Bhaskar Chaudhuri and David W. Osborne in June 2016 and is headquartered in Westlake Village, CA.